Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Systematic detection of putative tumor suppressor genes through the combined use of exome and transcriptome sequencing.

Zhao Q, Kirkness EF, Caballero OL, Galante PA, Parmigiani RB, Edsall L, Kuan S, Ye Z, Levy S, Vasconcelos AT, Ren B, de Souza SJ, Camargo AA, Simpson AJ, Strausberg RL.

Genome Biol. 2010;11(11):R114. doi: 10.1186/gb-2010-11-11-r114. Epub 2010 Nov 25.

PMID:
21108794
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Integrative analysis of genome-wide loss of heterozygosity and monoallelic expression at nucleotide resolution reveals disrupted pathways in triple-negative breast cancer.

Ha G, Roth A, Lai D, Bashashati A, Ding J, Goya R, Giuliany R, Rosner J, Oloumi A, Shumansky K, Chin SF, Turashvili G, Hirst M, Caldas C, Marra MA, Aparicio S, Shah SP.

Genome Res. 2012 Oct;22(10):1995-2007. doi: 10.1101/gr.137570.112. Epub 2012 May 25.

PMID:
22637570
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell lines.

Ha KC, Lalonde E, Li L, Cavallone L, Natrajan R, Lambros MB, Mitsopoulos C, Hakas J, Kozarewa I, Fenwick K, Lord CJ, Ashworth A, Vincent-Salomon A, Basik M, Reis-Filho JS, Majewski J, Foulkes WD.

BMC Med Genomics. 2011 Oct 27;4:75. doi: 10.1186/1755-8794-4-75.

PMID:
22032724
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.

Gao X, Porter AT, Honn KV.

Adv Exp Med Biol. 1997;407:41-53. Review.

PMID:
9321930
[PubMed - indexed for MEDLINE]
5.

Allele-specific loss of heterozygosity at the DAL-1/4.1B (EPB41L3) tumor-suppressor gene locus in the absence of mutation.

Kittiniyom K, Mastronardi M, Roemer M, Wells WA, Greenberg ER, Titus-Ernstoff L, Newsham IF.

Genes Chromosomes Cancer. 2004 Jul;40(3):190-203.

PMID:
15138999
[PubMed - indexed for MEDLINE]
6.

Sequencing, transcript identification, and quantitative gene expression profiling in the breast cancer loss of heterozygosity region 16q24.3 reveal three potential tumor-suppressor genes.

Powell JA, Gardner AE, Bais AJ, Hinze SJ, Baker E, Whitmore S, Crawford J, Kochetkova M, Spendlove HE, Doggett NA, Sutherland GR, Callen DF, Kremmidiotis G.

Genomics. 2002 Sep;80(3):303-10.

PMID:
12213200
[PubMed - indexed for MEDLINE]
7.

Expression analysis of candidate breast tumour suppressor genes on chromosome 16q.

van Wezel T, Lombaerts M, van Roon EH, Philippo K, Baelde HJ, Szuhai K, Cornelisse CJ, Cleton-Jansen AM.

Breast Cancer Res. 2005;7(6):R998-1004. Epub 2005 Oct 18.

PMID:
16280054
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.

Cvetkovic D, Pisarcik D, Lee C, Hamilton TC, Abdollahi A.

Gynecol Oncol. 2004 Dec;95(3):449-55.

PMID:
15581945
[PubMed - indexed for MEDLINE]
9.

Genome and transcriptome sequencing in prospective metastatic triple-negative breast cancer uncovers therapeutic vulnerabilities.

Craig DW, O'Shaughnessy JA, Kiefer JA, Aldrich J, Sinari S, Moses TM, Wong S, Dinh J, Christoforides A, Blum JL, Aitelli CL, Osborne CR, Izatt T, Kurdoglu A, Baker A, Koeman J, Barbacioru C, Sakarya O, De La Vega FM, Siddiqui A, Hoang L, Billings PR, Salhia B, Tolcher AW, Trent JM, Mousses S, Von Hoff D, Carpten JD.

Mol Cancer Ther. 2013 Jan;12(1):104-16. doi: 10.1158/1535-7163.MCT-12-0781. Epub 2012 Nov 19.

PMID:
23171949
[PubMed - indexed for MEDLINE]
Free Article
10.

Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.

Kloth JN, Oosting J, van Wezel T, Szuhai K, Knijnenburg J, Gorter A, Kenter GG, Fleuren GJ, Jordanova ES.

BMC Genomics. 2007 Feb 20;8:53.

PMID:
17311676
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

nFuse: discovery of complex genomic rearrangements in cancer using high-throughput sequencing.

McPherson A, Wu C, Wyatt AW, Shah S, Collins C, Sahinalp SC.

Genome Res. 2012 Nov;22(11):2250-61. doi: 10.1101/gr.136572.111. Epub 2012 Jun 28.

PMID:
22745232
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Rare and frequent promoter methylation, respectively, of TSHZ2 and 3 genes that are both downregulated in expression in breast and prostate cancers.

Yamamoto M, Cid E, Bru S, Yamamoto F.

PLoS One. 2011 Mar 14;6(3):e17149. doi: 10.1371/journal.pone.0017149.

PMID:
21423795
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray.

Yin D, Ogawa S, Kawamata N, Tunici P, Finocchiaro G, Eoli M, Ruckert C, Huynh T, Liu G, Kato M, Sanada M, Jauch A, Dugas M, Black KL, Koeffler HP.

Mol Cancer Res. 2009 May;7(5):665-77. doi: 10.1158/1541-7786.MCR-08-0270. Epub 2009 May 12.

PMID:
19435819
[PubMed - indexed for MEDLINE]
Free Article
14.

Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast.

Hawthorn L, Luce J, Stein L, Rothschild J.

BMC Cancer. 2010 Aug 27;10:460. doi: 10.1186/1471-2407-10-460.

PMID:
20799942
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Transcriptome-guided characterization of genomic rearrangements in a breast cancer cell line.

Zhao Q, Caballero OL, Levy S, Stevenson BJ, Iseli C, de Souza SJ, Galante PA, Busam D, Leversha MA, Chadalavada K, Rogers YH, Venter JC, Simpson AJ, Strausberg RL.

Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):1886-91. doi: 10.1073/pnas.0812945106. Epub 2009 Jan 30.

PMID:
19181860
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Multipoint methylation and expression analysis of tumor suppressor genes in human renal cancer cells.

Kawakami T, Okamoto K, Ogawa O, Okada Y.

Urology. 2003 Jan;61(1):226-30.

PMID:
12559313
[PubMed - indexed for MEDLINE]
17.

Whole-exome sequencing of human pancreatic cancers and characterization of genomic instability caused by MLH1 haploinsufficiency and complete deficiency.

Wang L, Tsutsumi S, Kawaguchi T, Nagasaki K, Tatsuno K, Yamamoto S, Sang F, Sonoda K, Sugawara M, Saiura A, Hirono S, Yamaue H, Miki Y, Isomura M, Totoki Y, Nagae G, Isagawa T, Ueda H, Murayama-Hosokawa S, Shibata T, Sakamoto H, Kanai Y, Kaneda A, Noda T, Aburatani H.

Genome Res. 2012 Feb;22(2):208-19. doi: 10.1101/gr.123109.111. Epub 2011 Dec 7.

PMID:
22156295
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Loss of heterozygosity and transcriptome analyses of a 1.2 Mb candidate ovarian cancer tumor suppressor locus region at 17q25.1-q25.2.

Presneau N, Dewar K, Forgetta V, Provencher D, Mes-Masson AM, Tonin PN.

Mol Carcinog. 2005 Jul;43(3):141-54.

PMID:
15937959
[PubMed - indexed for MEDLINE]
19.

High-throughput resequencing of target-captured cDNA in cancer cells.

Ueno T, Yamashita Y, Soda M, Fukumura K, Ando M, Yamato A, Kawazu M, Choi YL, Mano H.

Cancer Sci. 2012 Jan;103(1):131-5. doi: 10.1111/j.1349-7006.2011.02105.x. Epub 2011 Oct 13.

PMID:
21929543
[PubMed - indexed for MEDLINE]
20.

Genomic profiling of breast cancer.

Pandey A, Singh AK, Maurya SK, Rai R, Tewari M, Kumar M, Shukla HS.

J Surg Oncol. 2009 May 1;99(6):386-92. doi: 10.1002/jso.21249.

PMID:
19235775
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk